Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

• Alexander J,
• Gurwith M,
• Mendy J,
• Vang L,
• Manayani D,
• Avanzini J,
• Guenther B,
• Farness P,
• Haynes BF,
• Liao H,
• Montefiori DC,
• LaBranche CC,
• Mayall T

Affiliations

Alexander J

Gurwith M

Mendy J

Vang L

Manayani D

Avanzini J

Guenther B

Farness P

Haynes BF

Liao H

Montefiori DC

LaBranche CC

Mayall T